# TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus

> **NCT06748404** · PHASE2 · RECRUITING · sponsor: **University of California, San Diego** · enrollment: 28 (estimated)

## Conditions studied

- Immunotherapy-related Pruritus

## Interventions

- **DRUG:** Tricalm Hydrogel
- **DRUG:** Triamcinolone acetonide 0.1% cream

## Key facts

- **NCT ID:** NCT06748404
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-31
- **Primary completion:** 2027-12
- **Final completion:** 2028-12
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06748404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06748404, "TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06748404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*